Recall: D-0018-2027
Class II - Potentially Harmful
Class IIClassification
2026-09-10Initiated
OngoingStatus
Carolina Infusion, LLCFirm
Product
SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Distribution
Nationwide within the U.S
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.